MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
about
Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat gliomaIn vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.Novel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer modelImproved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.Imaging and cancer: a review.Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculatureTargeted molecular imaging.MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft modelTamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.Measuring tumour vascular response to antivascular and antiangiogenic drugs.MRI for assessing antivascular cancer treatments.Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbitsMolecular MR Imaging ProbesHigh sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 modelSignificance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media.Imaging myocardial angiogenesis.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Magnetic resonance imaging detects early changes in microvascular permeability in xenograft tumors after treatment with the matrix metalloprotease inhibitor Prinomastat.Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification.Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.
P2860
Q30581552-8C4A93EF-229C-4080-A298-3532FA707B05Q30979922-CBA141CE-9C91-4BEC-AE5F-BFE850F5FEEDQ30992467-B8C3A7CB-DEBF-48F3-9BD7-890B94767159Q33525581-7B05BB18-6B3C-44F8-8D79-F6E24498E2A7Q33744835-F0FB5BB2-FF9B-4D59-B58C-DE5FEFCCB274Q34306808-183C594A-4EDE-45B2-8776-8AB7890E693CQ34508475-284CB306-46DC-4470-B296-632687476FCCQ34977050-A5DD2C12-CC84-428B-8C1C-5D7D0E283F78Q35581064-CDCF8EBB-B6B4-4115-9017-8EFED6160009Q35581068-92C0C0CF-A9DF-4822-9158-CCAF55932C06Q35630559-BE312B27-39E7-4BF4-99B3-3DB66D00CA5CQ35880395-592C2164-54CB-4988-A0F2-42133D6572C7Q35884992-F8E62CE2-4746-4F83-AC7A-FEFD3BF5DAD2Q35904992-C4AC8DA2-9F59-4147-A44C-CFA02D8BAE1DQ35905005-C22B5F16-DB61-4A56-804B-C52A0F92DC24Q36804990-ED2E31AA-CC61-4EFF-B43F-659435EC4349Q37079267-9C56B4AB-DC98-4E49-8D8C-E58DDE186ABAQ37245368-9C7B330F-3181-41ED-A9E7-B4C63FCC937BQ37357319-A1DA57B7-2A4C-46A6-85B8-727300B692C9Q37422783-1785D4C6-D95B-41E7-90FE-5C2B08B5E5DFQ37593468-93979E5E-3965-4320-B11E-678C8A094898Q38168371-8DC276E1-E09F-494E-9323-F568B03AF5C8Q40532452-9D1D8CCD-A046-42D6-8CE9-8BC34A85A2DBQ41114248-A3BD3955-211C-4C52-B66A-974A3FF995ACQ43410555-38782238-16DF-44CB-AC8A-A4D240C4B89DQ47392014-7FF2EAFA-D958-403E-AD2C-3B7D7B8CF200Q51712155-0DEBAD65-6DBF-4313-A386-63E7DAD70D68
P2860
MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
MRI monitoring of tumor respon ...... tal human breast cancer model.
@ast
MRI monitoring of tumor respon ...... tal human breast cancer model.
@en
type
label
MRI monitoring of tumor respon ...... tal human breast cancer model.
@ast
MRI monitoring of tumor respon ...... tal human breast cancer model.
@en
prefLabel
MRI monitoring of tumor respon ...... tal human breast cancer model.
@ast
MRI monitoring of tumor respon ...... tal human breast cancer model.
@en
P2093
P1476
MRI monitoring of tumor respon ...... tal human breast cancer model.
@en
P2093
Anda Preda
David M Shames
Eugenia Floyd
Jeanette M Wood
Karl Turetschek
Robert C Brasch
Timothy P L Roberts
Viktor Novikov
Wayne O Carter
P2888
P304
P356
10.1007/S00259-002-1000-5
P577
2003-03-01T00:00:00Z